Hepatic sarcoidosis
Sarcoidosis is a multisystem disease of unknown aetiology. Histological evidence of non-caseating granulomas represents the main finding. It affects mostly young people, targeting primary the lung and hilar lymph nodes although liver involvement is often encountered. Hepatic sarcoidosis covers a bro...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-10-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119319830 |
id |
doaj-9f20921dab6040ddac8438be2e071c68 |
---|---|
record_format |
Article |
spelling |
doaj-9f20921dab6040ddac8438be2e071c682021-06-08T04:36:07ZengElsevierAnnals of Hepatology1665-26812006-10-0154251256Hepatic sarcoidosisAlexandras Karagiannidis0Maria Karavalaki1Anastasios Koulaouzidis2Associate Specialist in Gastroenterology, AHEPA General Hospital, Thessaloniki, Greece; Address for correspondence:Trainee in General Surgery, “St Demitrios” General Hospital of Thessaloniki, GreeceSpecialist Registrar, Gastroenterology, Warrington Hospital, UKSarcoidosis is a multisystem disease of unknown aetiology. Histological evidence of non-caseating granulomas represents the main finding. It affects mostly young people, targeting primary the lung and hilar lymph nodes although liver involvement is often encountered. Hepatic sarcoidosis covers a broad spectrum from asymptomatic hepatic granulomas formation and slightly deranged liver function tests to clinically evident disease with cholestasis or, in advanced cases, cirrhosis and portal hypertension. Other granulomatous diseases (mainly systemic infections like tuberculosis) should be excluded prior to treatment, as longstanding corticosteroid administration is the main stem of therapy. In advanced cases, liver transplantation represents the ultimate therapeutic option.http://www.sciencedirect.com/science/article/pii/S1665268119319830Liver granulomaidiopathic granulomatous hepatitischolestasishepatic sarcoidosisliver sarcoid |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexandras Karagiannidis Maria Karavalaki Anastasios Koulaouzidis |
spellingShingle |
Alexandras Karagiannidis Maria Karavalaki Anastasios Koulaouzidis Hepatic sarcoidosis Annals of Hepatology Liver granuloma idiopathic granulomatous hepatitis cholestasis hepatic sarcoidosis liver sarcoid |
author_facet |
Alexandras Karagiannidis Maria Karavalaki Anastasios Koulaouzidis |
author_sort |
Alexandras Karagiannidis |
title |
Hepatic sarcoidosis |
title_short |
Hepatic sarcoidosis |
title_full |
Hepatic sarcoidosis |
title_fullStr |
Hepatic sarcoidosis |
title_full_unstemmed |
Hepatic sarcoidosis |
title_sort |
hepatic sarcoidosis |
publisher |
Elsevier |
series |
Annals of Hepatology |
issn |
1665-2681 |
publishDate |
2006-10-01 |
description |
Sarcoidosis is a multisystem disease of unknown aetiology. Histological evidence of non-caseating granulomas represents the main finding. It affects mostly young people, targeting primary the lung and hilar lymph nodes although liver involvement is often encountered. Hepatic sarcoidosis covers a broad spectrum from asymptomatic hepatic granulomas formation and slightly deranged liver function tests to clinically evident disease with cholestasis or, in advanced cases, cirrhosis and portal hypertension. Other granulomatous diseases (mainly systemic infections like tuberculosis) should be excluded prior to treatment, as longstanding corticosteroid administration is the main stem of therapy. In advanced cases, liver transplantation represents the ultimate therapeutic option. |
topic |
Liver granuloma idiopathic granulomatous hepatitis cholestasis hepatic sarcoidosis liver sarcoid |
url |
http://www.sciencedirect.com/science/article/pii/S1665268119319830 |
work_keys_str_mv |
AT alexandraskaragiannidis hepaticsarcoidosis AT mariakaravalaki hepaticsarcoidosis AT anastasioskoulaouzidis hepaticsarcoidosis |
_version_ |
1721390942971232256 |